Ishikawa N - Search Results

1

Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis.

Ohshimo S, Ishikawa N, Horimasu Y, Hattori N, Hirohashi N, Tanigawa K, Kohno N, Bonella F, Guzman J, Costabel U. Ohshimo S, et al. Among authors: ishikawa n. Respir Med. 2014 Jul;108(7):1031-9. doi: 10.1016/j.rmed.2014.04.009. Epub 2014 Apr 26. Respir Med. 2014. PMID: 24835074 Free article.

2

Association between expression of the MRP3 gene and exposure to platinum drugs in lung cancer.

Oguri T, Isobe T, Fujitaka K, Ishikawa N, Kohno N. Oguri T, et al. Among authors: ishikawa n. Int J Cancer. 2001 Aug 15;93(4):584-9. doi: 10.1002/ijc.1369. Int J Cancer. 2001. PMID: 11477564

3

SGLT gene expression in primary lung cancers and their metastatic lesions.

Ishikawa N, Oguri T, Isobe T, Fujitaka K, Kohno N. Ishikawa N, et al. Jpn J Cancer Res. 2001 Aug;92(8):874-9. doi: 10.1111/j.1349-7006.2001.tb01175.x. Jpn J Cancer Res. 2001. PMID: 11509120 Free PMC article.

4

Usefulness of the modified lavage technique of Bingisser and KL-6 monitoring in a patient with pulmonary alveolar proteinosis.

Ishikawa N, Kondo K, Oguri T, Kamitsuna M, Sakurai J, Fujitaka K, Yamasaki M, Maeda H, Isobe T, Kohno N. Ishikawa N, et al. Intern Med. 2002 May;41(5):381-5. doi: 10.2169/internalmedicine.41.381. Intern Med. 2002. PMID: 12058888 Free article.

5

KL-6 as an indicator for lymphocytic interstitial pneumonia (LIP) in a human T-lymphotrophic virus type 1 (HTLV-1) carrier.

Ishikawa N, Awaya Y, Maeda H, Miyazaki M, Fujitaka K, Yamasaki M, Kondo K, Oguri T, Isobe T, Kohno N. Ishikawa N, et al. Ann Hematol. 2002 Aug;81(8):474-7. doi: 10.1007/s00277-002-0465-4. Epub 2002 Jul 31. Ann Hematol. 2002. PMID: 12224007

6

ADAM8 as a novel serological and histochemical marker for lung cancer.

Ishikawa N, Daigo Y, Yasui W, Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y. Ishikawa N, et al. Clin Cancer Res. 2004 Dec 15;10(24):8363-70. doi: 10.1158/1078-0432.CCR-04-1436. Clin Cancer Res. 2004. PMID: 15623614

7

Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers.

Ishikawa N, Daigo Y, Takano A, Taniwaki M, Kato T, Hayama S, Murakami H, Takeshima Y, Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y. Ishikawa N, et al. Cancer Res. 2005 Oct 15;65(20):9176-84. doi: 10.1158/0008-5472.CAN-05-1556. Cancer Res. 2005. PMID: 16230376

8

KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts.

Ohshimo S, Yokoyama A, Hattori N, Ishikawa N, Hirasawa Y, Kohno N. Ohshimo S, et al. Among authors: ishikawa n. Biochem Biophys Res Commun. 2005 Dec 30;338(4):1845-52. doi: 10.1016/j.bbrc.2005.10.144. Epub 2005 Nov 2. Biochem Biophys Res Commun. 2005. PMID: 16289035

9

Anti-tumor effect of the anti-KL-6/MUC1 monoclonal antibody through exposure of surface molecules by MUC1 capping.

Doi M, Yokoyama A, Kondo K, Ohnishi H, Ishikawa N, Hattori N, Kohno N. Doi M, et al. Among authors: ishikawa n. Cancer Sci. 2006 May;97(5):420-9. doi: 10.1111/j.1349-7006.2006.00183.x. Cancer Sci. 2006. PMID: 16630141 Free PMC article.

10

Gene expression profiles of small-cell lung cancers: molecular signatures of lung cancer.

Taniwaki M, Daigo Y, Ishikawa N, Takano A, Tsunoda T, Yasui W, Inai K, Kohno N, Nakamura Y. Taniwaki M, et al. Among authors: ishikawa n. Int J Oncol. 2006 Sep;29(3):567-75. Int J Oncol. 2006. PMID: 16865272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,627 results

Search Page

Filters